Royce & Associates’s Guardian Pharmacy Services GRDN Stock Holding History

Royce & Associates’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.28M	Sell	87,096 -99,026	-53%	-$3.24M	0.03%	521
2025 Q4	$5.6M	Sell	186,122 -82,015	-31%	-$2.32M	0.06%	444
2025 Q3	$7.03M	Buy	268,137 +12,491	+5%	+$298K	0.07%	398
2025 Q2	$5.45M	Sell	255,646 -17,422	-6%	-$393K	0.06%	443
2025 Q1	$5.81M	Buy	273,068 +59,068	+28%	+$1.21M	0.06%	414
2024 Q4	$4.34M	Buy	214,000 +139,000	+185%	+$2.87M	0.04%	515
2024 Q3	$1.26M	Buy	+75,000	New	+$1.26M	0.01%	698

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Royce & Associates's GRDN Position: Q1 2026 in Review

Royce & Associates reduced its Guardian Pharmacy Services (GRDN) stake by 53% in Q1 2026, selling an estimated $3.24M and leaving 87,096 shares worth $3.28M. The position accounts for 0.03% of the portfolio, ranked #521.

Royce & Associates first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. The position peaked at $7.03M in Q3 2025. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

Royce & Associates held 87,096 shares of Guardian Pharmacy Services worth $3.28M as of Q1 2026.
Royce & Associates sold 99,026 Guardian Pharmacy Services shares in Q1 2026, an estimated $3.24M.
Guardian Pharmacy Services made up 0.03% of Royce & Associates's portfolio in Q1 2026, its #521 holding.
Royce & Associates first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
Royce & Associates's Guardian Pharmacy Services position peaked at $7.03M in Q3 2025.
171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.